Cerrado Gold (CRDOF) has been upgraded to a Buy rating due to improved production at its Minera Don Nicolas (MDN) mine, which reached 15,415 gold equivalent ounces in Q2, supporting the annual target of 50,000 GEO. However, cost control remains a challenge as all-in sustaining costs rose to $1,933 per ounce. The delay of the Mont Sorcier feasibility study to the first half of 2027 removes a near-term catalyst, making the stock more speculative and shifting focus to MDN's cash flow. Strategic stream buybacks and elimination of expensive debt enhance long-term value, but effective capital allocation and cost management are critical for the company to achieve self-funding status.
Cerrado Gold's operational update provides context for readers interested in gold and mining-related assets. For readers following the broader US stock market on Pluang, here is the market snapshot as of Oct 05, 2026 19:01 WIB: out of 150 priced US stocks, 87 rose and 56 fell today. Notable movers include Nu Holdings Ltd (NU) with a 13.18% gain at USD 15.20 and a typical hold time of 53 days, contrasting with United Microelectronics Corp (UMC) which dropped 8.37% to USD 24.07 and is held typically for 42 days. Vale SA (VALE) also rose 6.14% to USD 14.61 with a longer typical hold time of 109 days, illustrating varied investor engagement across these assets.
Bank of America upgraded DraftKings stock to Buy from Neutral, citing reduced risks from prediction markets and a favorable risk-reward at current prices. DraftKings shares rose 5% following the upgrade, while competitors Flutter Entertainment and MG...
Vertiv has named Michael Resha as Executive Vice President of Manufacturing, Logistics, and Operational Excellence, succeeding Anders Karlborg who moves to a new role. Resha will lead global manufacturing and logistics efforts to scale operations and...
Bitmine increased its Ether (ETH) holdings by 15,112 coins last week, bringing its total to 6,016,414 ETH. This accumulation highlights Bitmine's ongoing investment in Ethereum, signaling confidence in the digital asset's future. The move may influen...
Rapid Dose Therapeutics announced it will issue common shares to settle $142,067.63 of accrued interest on its secured convertible notes by October 15, 2026. The notes, originally issued in 2023, bear 18% annual interest payable quarterly in shares a...
JP Morgan has put Unilever on positive watch and Haleon on negative watch ahead of the third-quarter earnings reports from European consumer staples companies. The broker also favors Givaudan, Heineken, and Danone, particularly in beer, ingredients, ...
